TRDA filings
Corporate insider profile
Nathan J Dowden Filing Activity
Latest reported as President & COO of Entrada Therapeutics, Inc. (TRDA).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$229,953.00
- Latest transaction
- May 4, 2026
Affiliated corporations
Reported company relationships
Transaction history
